Respiratory Diagnostics Market is estimated to increase at a Compounded Annual Growth Rate of 7.6% CAGR over the forecast period from 2024 to 2030
The Respiratory Diagnostics Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Products and Services (Instruments & Devices, Assays & Reagents, Services & Software), By Test (Mechanical Tests, Osa Diagnostic Tests, Imaging Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests), By Indication (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease, Others), By End-User (Hospitals and Clinics, Diagnostics Laboratories, Others).
An Introduction to Respiratory Diagnostics Market in 2024
Respiratory diagnostics involve the assessment and evaluation of respiratory function, anatomy, and pathology through various diagnostic tests and imaging modalities. In 2024, the market for respiratory diagnostics continues to advance, driven by the increasing prevalence of respiratory diseases, the demand for accurate and timely diagnosis, and technological innovations in diagnostic techniques. Respiratory diagnostics encompass a range of tests, including pulmonary function tests (PFTs), imaging studies such as chest X-rays and computed tomography (CT) scans, bronchoscopy, sputum analysis, and molecular diagnostics for respiratory pathogens. These diagnostic tests enable healthcare providers to assess lung function, detect abnormalities, diagnose respiratory conditions such as asthma, chronic bronchitis, and lung cancer, and monitor disease progression or treatment response. With advancements in imaging resolution, biomarker detection, and point-of-care testing, respiratory diagnostics offer improved accuracy, sensitivity, and efficiency for diagnosing respiratory disorders across various healthcare settings. Moreover, the integration of artificial intelligence (AI), machine learning algorithms, and digital pathology platforms enhances diagnostic accuracy, facilitates data interpretation, and supports clinical decision-making in respiratory care. As the burden of respiratory diseases continues to grow globally, respiratory diagnostics play a crucial role in early detection, personalized treatment planning, and optimizing outcomes for patients with respiratory conditions, ultimately improving patient care and reducing healthcare disparities.
Market Trend: Adoption of Point-of-Care Respiratory Diagnostic Testing
A prominent trend in the respiratory diagnostics market is the increasing adoption of point-of-care (POC) respiratory diagnostic testing. With the growing burden of respiratory infections, chronic respiratory diseases, and the ongoing COVID-19 pandemic, there's a rising demand for rapid and accurate diagnostic tests that can be performed at the point of care. POC respiratory diagnostic tests offer several advantages, including rapid turnaround times, decentralized testing, and immediate treatment decisions, enabling timely identification of respiratory pathogens and appropriate patient management. This trend reflects the shift towards decentralized healthcare delivery models and the need for rapid diagnostic solutions to support early detection, infection control, and public health response efforts.
Market Driver: Rising Incidence of Respiratory Diseases and Infections
A key driver propelling the growth of the respiratory diagnostics market is the rising incidence of respiratory diseases and infections worldwide. Respiratory infections, such as influenza, respiratory syncytial virus (RSV), and pneumonia, remain a leading cause of morbidity and mortality globally, particularly among vulnerable populations such as infants, elderly individuals, and immunocompromised patients. Additionally, the prevalence of chronic respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), and lung cancer, continues to increase due to factors such as air pollution, smoking, and aging populations. The growing burden of respiratory conditions drives the demand for accurate and timely diagnostic tests to facilitate early detection, differential diagnosis, and appropriate management, thereby propelling market growth in the respiratory diagnostics segment.
Market Opportunity: Development of Multiplex Respiratory Panels and Next-Generation Sequencing
An emerging opportunity in the respiratory diagnostics market lies in the development of multiplex respiratory panels and next-generation sequencing (NGS) technologies. Multiplex respiratory panels enable simultaneous detection and identification of multiple respiratory pathogens, including viruses, bacteria, and fungi, from a single clinical sample. These panels offer advantages such as increased sensitivity, specificity, and throughput compared to traditional diagnostic methods, facilitating comprehensive respiratory pathogen profiling and differential diagnosis in patients with acute respiratory infections. Additionally, advancements in NGS technologies allow for unbiased and high-throughput sequencing of respiratory pathogens' genomes, enabling characterization of viral strains, identification of emerging pathogens, and monitoring of antimicrobial resistance patterns. By investing in the development and commercialization of multiplex respiratory panels and NGS-based respiratory diagnostics, companies can address unmet needs in respiratory disease management, enhance diagnostic accuracy, and drive innovation in the respiratory diagnostics market.
Respiratory Diagnostics Market Share Analysis: Molecular Diagnostic Tests is the fastest growing segment over the forecast period to 2030
Among the provided segments, Molecular Diagnostic Tests are the fastest growing in the Respiratory Diagnostics Market. This growth can be attributed to several factors. Firstly, molecular diagnostic tests offer high sensitivity, specificity, and rapid detection of respiratory pathogens, making them invaluable tools for diagnosing infectious respiratory diseases such as tuberculosis, influenza, and COVID-19. The ongoing global pandemic has highlighted the critical role of molecular testing in identifying and managing respiratory infections, driving the demand for PCR (Polymerase Chain Reaction) and nucleic acid amplification tests. Additionally, advancements in molecular biology techniques and automation technologies have streamlined test workflows, reduced turnaround times, and expanded testing capacity, enhancing the accessibility and efficiency of molecular diagnostic testing for respiratory diseases. Furthermore, the emergence of new viral variants and the potential for future pandemics underscore the importance of continuous innovation and investment in molecular diagnostics for respiratory pathogens. Moreover, the increasing adoption of personalized medicine approaches and targeted therapies in respiratory care further drives the demand for molecular diagnostic tests for genotype and mutation analysis in lung cancer and other respiratory conditions. As a result, Molecular Diagnostic Tests emerge as the fastest growing segment in the Respiratory Diagnostics Market, addressing the evolving needs of healthcare providers and patients for accurate and timely diagnosis of respiratory diseases effectively.
Respiratory Diagnostics Competitive Analysis
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAbbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, BIRD Healthcare, Briota Technologies Private Ltd, Compumedics Ltd, GE Healthcare, Hologic Inc, Koninklijke Philips N.V., Löwenstein Medical Technology, ndd Medizintechnik AG, Nihon Kohden Corp, ProAxsis Ltd, QIAGEN N.V., ResMed Inc, Revvity Inc, SDI Diagnostics Inc, Seegene Inc, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc, VisBy Medical Inc, Vitalograph Ltd, Vyaire Medical Inc
Respiratory Diagnostics Market Segmentation
By Products and Services
Instruments & Devices
Assays & Reagents
Services & Software
By Test
Mechanical Tests
-Pulmonary Function Tests
-Spirometry
-Peak Flow Test
Osa Diagnostic Tests
Imaging Tests
-X-Ray
-Computed Tomography
-Magnetic Resonance Imaging (MRI)
-Positron Emission Tomography (PET)
-Others
Traditional Diagnostic Tests
-Immunodiagnostics
-Biochemical Tests
-Microscopy
Molecular Diagnostic Tests
-PCR
-Nucleic Acid Amplification Test
-In Situ Hybridization
-DNA Sequencing & Next-Generation Sequencing (NGS)
-Microarrays
-Others
By Indication
Tuberculosis
Asthma
Lung Cancer
Chronic Obstructive Pulmonary Disease
Others
By End-User
Hospitals and Clinics
Diagnostics Laboratories
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Respiratory Diagnostics Market Companies
Abbott Laboratories
Becton, Dickinson and Company
bioMérieux SA
Bio-Rad Laboratories Inc
BIRD Healthcare
Briota Technologies Private Ltd
Compumedics Ltd
GE Healthcare
Hologic Inc
Koninklijke Philips N.V.
Löwenstein Medical Technology
ndd Medizintechnik AG
Nihon Kohden Corp
ProAxsis Ltd
QIAGEN N.V.
ResMed Inc
Revvity Inc
SDI Diagnostics Inc
Seegene Inc
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc
VisBy Medical Inc
Vitalograph Ltd
Vyaire Medical Inc
Reasons to Buy the Respiratory Diagnostics Market Study
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Respiratory Diagnostics Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Respiratory Diagnostics Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Respiratory Diagnostics Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Respiratory Diagnostics Market Size Outlook, $ Million, 2021 to 2030
3.2 Respiratory Diagnostics Market Outlook by Type, $ Million, 2021 to 2030
3.3 Respiratory Diagnostics Market Outlook by Product, $ Million, 2021 to 2030
3.4 Respiratory Diagnostics Market Outlook by Application, $ Million, 2021 to 2030
3.5 Respiratory Diagnostics Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Respiratory Diagnostics Industry
4.2 Key Market Trends in Respiratory Diagnostics Industry
4.3 Potential Opportunities in Respiratory Diagnostics Industry
4.4 Key Challenges in Respiratory Diagnostics Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Respiratory Diagnostics Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Respiratory Diagnostics Market Outlook by Segments
7.1 Respiratory Diagnostics Market Outlook by Segments, $ Million, 2021- 2030
By Products and Services
Instruments & Devices
Assays & Reagents
Services & Software
By Test
Mechanical Tests
-Pulmonary Function Tests
-Spirometry
-Peak Flow Test
Osa Diagnostic Tests
Imaging Tests
-X-Ray
-Computed Tomography
-Magnetic Resonance Imaging (MRI)
-Positron Emission Tomography (PET)
-Others
Traditional Diagnostic Tests
-Immunodiagnostics
-Biochemical Tests
-Microscopy
Molecular Diagnostic Tests
-PCR
-Nucleic Acid Amplification Test
-In Situ Hybridization
-DNA Sequencing & Next-Generation Sequencing (NGS)
-Microarrays
-Others
By Indication
Tuberculosis
Asthma
Lung Cancer
Chronic Obstructive Pulmonary Disease
Others
By End-User
Hospitals and Clinics
Diagnostics Laboratories
Others
8 North America Respiratory Diagnostics Market Analysis and Outlook To 2030
8.1 Introduction to North America Respiratory Diagnostics Markets in 2024
8.2 North America Respiratory Diagnostics Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Respiratory Diagnostics Market size Outlook by Segments, 2021-2030
By Products and Services
Instruments & Devices
Assays & Reagents
Services & Software
By Test
Mechanical Tests
-Pulmonary Function Tests
-Spirometry
-Peak Flow Test
Osa Diagnostic Tests
Imaging Tests
-X-Ray
-Computed Tomography
-Magnetic Resonance Imaging (MRI)
-Positron Emission Tomography (PET)
-Others
Traditional Diagnostic Tests
-Immunodiagnostics
-Biochemical Tests
-Microscopy
Molecular Diagnostic Tests
-PCR
-Nucleic Acid Amplification Test
-In Situ Hybridization
-DNA Sequencing & Next-Generation Sequencing (NGS)
-Microarrays
-Others
By Indication
Tuberculosis
Asthma
Lung Cancer
Chronic Obstructive Pulmonary Disease
Others
By End-User
Hospitals and Clinics
Diagnostics Laboratories
Others
9 Europe Respiratory Diagnostics Market Analysis and Outlook To 2030
9.1 Introduction to Europe Respiratory Diagnostics Markets in 2024
9.2 Europe Respiratory Diagnostics Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Respiratory Diagnostics Market Size Outlook by Segments, 2021-2030
By Products and Services
Instruments & Devices
Assays & Reagents
Services & Software
By Test
Mechanical Tests
-Pulmonary Function Tests
-Spirometry
-Peak Flow Test
Osa Diagnostic Tests
Imaging Tests
-X-Ray
-Computed Tomography
-Magnetic Resonance Imaging (MRI)
-Positron Emission Tomography (PET)
-Others
Traditional Diagnostic Tests
-Immunodiagnostics
-Biochemical Tests
-Microscopy
Molecular Diagnostic Tests
-PCR
-Nucleic Acid Amplification Test
-In Situ Hybridization
-DNA Sequencing & Next-Generation Sequencing (NGS)
-Microarrays
-Others
By Indication
Tuberculosis
Asthma
Lung Cancer
Chronic Obstructive Pulmonary Disease
Others
By End-User
Hospitals and Clinics
Diagnostics Laboratories
Others
10 Asia Pacific Respiratory Diagnostics Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Respiratory Diagnostics Markets in 2024
10.2 Asia Pacific Respiratory Diagnostics Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Respiratory Diagnostics Market size Outlook by Segments, 2021-2030
By Products and Services
Instruments & Devices
Assays & Reagents
Services & Software
By Test
Mechanical Tests
-Pulmonary Function Tests
-Spirometry
-Peak Flow Test
Osa Diagnostic Tests
Imaging Tests
-X-Ray
-Computed Tomography
-Magnetic Resonance Imaging (MRI)
-Positron Emission Tomography (PET)
-Others
Traditional Diagnostic Tests
-Immunodiagnostics
-Biochemical Tests
-Microscopy
Molecular Diagnostic Tests
-PCR
-Nucleic Acid Amplification Test
-In Situ Hybridization
-DNA Sequencing & Next-Generation Sequencing (NGS)
-Microarrays
-Others
By Indication
Tuberculosis
Asthma
Lung Cancer
Chronic Obstructive Pulmonary Disease
Others
By End-User
Hospitals and Clinics
Diagnostics Laboratories
Others
11 South America Respiratory Diagnostics Market Analysis and Outlook To 2030
11.1 Introduction to South America Respiratory Diagnostics Markets in 2024
11.2 South America Respiratory Diagnostics Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Respiratory Diagnostics Market size Outlook by Segments, 2021-2030
By Products and Services
Instruments & Devices
Assays & Reagents
Services & Software
By Test
Mechanical Tests
-Pulmonary Function Tests
-Spirometry
-Peak Flow Test
Osa Diagnostic Tests
Imaging Tests
-X-Ray
-Computed Tomography
-Magnetic Resonance Imaging (MRI)
-Positron Emission Tomography (PET)
-Others
Traditional Diagnostic Tests
-Immunodiagnostics
-Biochemical Tests
-Microscopy
Molecular Diagnostic Tests
-PCR
-Nucleic Acid Amplification Test
-In Situ Hybridization
-DNA Sequencing & Next-Generation Sequencing (NGS)
-Microarrays
-Others
By Indication
Tuberculosis
Asthma
Lung Cancer
Chronic Obstructive Pulmonary Disease
Others
By End-User
Hospitals and Clinics
Diagnostics Laboratories
Others
12 Middle East and Africa Respiratory Diagnostics Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Respiratory Diagnostics Markets in 2024
12.2 Middle East and Africa Respiratory Diagnostics Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Respiratory Diagnostics Market size Outlook by Segments, 2021-2030
By Products and Services
Instruments & Devices
Assays & Reagents
Services & Software
By Test
Mechanical Tests
-Pulmonary Function Tests
-Spirometry
-Peak Flow Test
Osa Diagnostic Tests
Imaging Tests
-X-Ray
-Computed Tomography
-Magnetic Resonance Imaging (MRI)
-Positron Emission Tomography (PET)
-Others
Traditional Diagnostic Tests
-Immunodiagnostics
-Biochemical Tests
-Microscopy
Molecular Diagnostic Tests
-PCR
-Nucleic Acid Amplification Test
-In Situ Hybridization
-DNA Sequencing & Next-Generation Sequencing (NGS)
-Microarrays
-Others
By Indication
Tuberculosis
Asthma
Lung Cancer
Chronic Obstructive Pulmonary Disease
Others
By End-User
Hospitals and Clinics
Diagnostics Laboratories
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
Becton, Dickinson and Company
bioMérieux SA
Bio-Rad Laboratories Inc
BIRD Healthcare
Briota Technologies Private Ltd
Compumedics Ltd
GE Healthcare
Hologic Inc
Koninklijke Philips N.V.
Löwenstein Medical Technology
ndd Medizintechnik AG
Nihon Kohden Corp
ProAxsis Ltd
QIAGEN N.V.
ResMed Inc
Revvity Inc
SDI Diagnostics Inc
Seegene Inc
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc
VisBy Medical Inc
Vitalograph Ltd
Vyaire Medical Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Products and Services
Instruments & Devices
Assays & Reagents
Services & Software
By Test
Mechanical Tests
-Pulmonary Function Tests
-Spirometry
-Peak Flow Test
Osa Diagnostic Tests
Imaging Tests
-X-Ray
-Computed Tomography
-Magnetic Resonance Imaging (MRI)
-Positron Emission Tomography (PET)
-Others
Traditional Diagnostic Tests
-Immunodiagnostics
-Biochemical Tests
-Microscopy
Molecular Diagnostic Tests
-PCR
-Nucleic Acid Amplification Test
-In Situ Hybridization
-DNA Sequencing & Next-Generation Sequencing (NGS)
-Microarrays
-Others
By Indication
Tuberculosis
Asthma
Lung Cancer
Chronic Obstructive Pulmonary Disease
Others
By End-User
Hospitals and Clinics
Diagnostics Laboratories
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
